Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery

NCT ID: NCT00952315

Last Updated: 2019-07-05

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

270 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-08-31

Study Completion Date

2017-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators plan to compare three different devices that are used to break up large kidney stones during surgery for removal to see if one is faster or more efficient than the others.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Large kidney stones can be removed by a surgical procedure where a small puncture is made through the back into the kidney (percutaneous nephrolithotomy or PNL) but the stones usually need to be broken into smaller pieces before they can be removed through the small surgical incision. There are a number of FDA approved devices commercially available used to break up the stones including pneumatic, ultrasonic, and a combination of the two. Each technology has advantages and disadvantages.

In the last few years there have been new, improved versions of these devices introduced. These improved versions have addressed previous issues of probes clogging or breaking and cumbersome handpiece design. These include the Cyberwand (Cybersonics, Erie, PA), a dual probe ultrasonic device, Swiss Lithoclast Select (EMS, Switzerland) combining the pneumatic and ultrasonic modalities, and a novel device by LMA (Gland, Switzerland) called the StoneBreakerTM, a portable pneumatic device powered by CO2 cartridges.

We propose to compare each of these devices in a randomized study to see if one is better than another at removing kidney stones quickly and efficiently.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Stones

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stonebreaker

Stonebreaker will be used to break up the kidney stone. Duration will be timed and documented.

Group Type ACTIVE_COMPARATOR

Stonebreaker

Intervention Type DEVICE

Stonebreaker will be used to break up the kidney stone. Duration will be timed and documented.

Lithoclast Select

Lithoclast Select will be used to breakup and remove kidney stone. Duration will be timed and documented.

Group Type ACTIVE_COMPARATOR

Lithoclast Select

Intervention Type DEVICE

Lithoclast Select will be used to break up and remove the kidney stone. Duration will be timed and documented

Cyberwand

The dual probe Cyberwand device will be used to fragment and remove the kidney stone. Duration will be timed and documented.

Group Type ACTIVE_COMPARATOR

Cyberwand

Intervention Type DEVICE

Dual probe lithotrite Cyberwand will be used to remove kidney stone. Duration will be timed and documented.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cyberwand

Dual probe lithotrite Cyberwand will be used to remove kidney stone. Duration will be timed and documented.

Intervention Type DEVICE

Stonebreaker

Stonebreaker will be used to break up the kidney stone. Duration will be timed and documented.

Intervention Type DEVICE

Lithoclast Select

Lithoclast Select will be used to break up and remove the kidney stone. Duration will be timed and documented

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Scheduled to undergo percutaneous nephrolithotomy for at least one kidney stone measuring 2 cm or greater
* Stone easily visible/measurable on plain abdominal imaging (KUB) or CT scan preoperatively
* Age 18 years or older
* Able to give informed consent

Exclusion Criteria

* Size of single largest stone less than 2 cm
* Pregnancy
* Active urinary tract infection
* Extracorporeal shockwave lithotripsy within the last three months
* Complex stone anticipating multiple access sites
* Stones that are not clearly able to be measured on KUB or CT scan
* Inability to give informed consent
* Age less than 18 years
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Indiana Kidney Stone Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

James Lingeman

James Lingeman, MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

James E Lingeman, MD

Role: PRINCIPAL_INVESTIGATOR

IU Health Physicians Urology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Clinic Scottsdale

Phoenix, Arizona, United States

Site Status

Northwestern University

Chicago, Illinois, United States

Site Status

IU Health Physicians Urology

Indianapolis, Indiana, United States

Site Status

Johns Hopkins

Baltimore, Maryland, United States

Site Status

Mayo Clinic Rochester

Rochester, Minnesota, United States

Site Status

Duke University

Durham, North Carolina, United States

Site Status

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

University of Wisconsin

Madison, Wisconsin, United States

Site Status

University of British Columbia

Vancouver, British Columbia, Canada

Site Status

The University of Western Ontario

London, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

Related Links

Access external resources that provide additional context or updates about the study.

http://iksi.org

International Kidney Stone Institute - Click here for more information about kidney stone disease

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

09-045

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lithotripsy for the Treatment of Gallstones
NCT00042549 TERMINATED PHASE4
Struvite Stones Antibiotic Study
NCT02375295 UNKNOWN PHASE4
Management of Medium Sized Renal Stones
NCT06720311 NOT_YET_RECRUITING NA
Ultrasound Imaging of Kidney Stones and Lithotripsy
NCT02214836 ACTIVE_NOT_RECRUITING NA